{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:31:23Z","timestamp":1786649483451,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>To diagnose a case anti-MuSK myasthenia gravis (anti-MuSK MG) is always a challenge in view of a distinct clinical phenotype that differs from typical MG (anti-acetylcholine receptors (antibody positive). We herein report a case of anti-MuSK MG, whose history and clinical phenotype differ from typical MG and are more suggestive of myopathy or anterior horn cell disease. Therefore, testing anti-MuSK antibody is very important if there is suspicion of anti-MuSK MG.<\/jats:p>","DOI":"10.4103\/ant.ant_113_0051","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T09:00:15Z","timestamp":1767085215000},"page":"232-234","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["A Case of Anti-MuSK Antibody-positive Myasthenia Gravis Presenting as Limb-Girdle Muscle Atrophy"],"prefix":"10.4103","volume":"34","author":[{"given":"Hemanga Kumar","family":"Dhing","sequence":"first","affiliation":[{"name":"Department of Neurology, All India Institute of Medical Sciences, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaraf","family":"Hussain","sequence":"additional","affiliation":[{"name":"Department of Neurology, All India Institute of Medical Sciences, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabal","family":"Nath","sequence":"additional","affiliation":[{"name":"Department of Neurology, All India Institute of Medical Sciences, Guwahati, Assam, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"R1-20251230","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1126\/science.180.4088.871","article-title":"Autoimmune response to acetylcholine receptor","volume":"180","author":"Patrick","year":"1973","journal-title":"Science"},{"key":"R2-20251230","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann Neurol"},{"key":"R3-20251230","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","article-title":"Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis","volume":"69","author":"Higuchi","year":"2011","journal-title":"Ann Neurol"},{"key":"R4-20251230","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"key":"R5-20251230","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11940-014-0283-8","article-title":"Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase","volume":"16","author":"El-Salem","year":"2014","journal-title":"Curr Treat Options Neurol"},{"key":"R6-20251230","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.autrev.2013.03.004","article-title":"Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase","volume":"12","author":"Evoli","year":"2013","journal-title":"Autoimmun Rev"},{"key":"R7-20251230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/joa.12034","article-title":"The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis","volume":"224","author":"Koneczny","year":"2014","journal-title":"J Anat"},{"key":"R8-20251230","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1552-6569.2009.00456.x","article-title":"MRI evidence of early muscle atrophy in MuSK positive myasthenia gravis","volume":"21","author":"Zouvelou","year":"2011","journal-title":"J Neuroimaging"},{"key":"R9-20251230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2008.05.032","article-title":"MuSK-antibody positive myasthenia gravis: Questions from the clinic","volume":"201-2","author":"Sanders","year":"2008","journal-title":"J Neuroimmunol"},{"key":"R10-20251230","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"R11-20251230","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00415-010-5823-x","article-title":"Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies","volume":"258","author":"Cenacchi","year":"2011","journal-title":"J Neurol"},{"key":"R12-20251230","first-page":"100846","article-title":"A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: The SCREAM study","volume":"38","author":"Li","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"R13-20251230","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s00415-022-11458-4","article-title":"Clinical pitfalls and serological diagnostics of MuSK myasthenia gravis","volume":"270","author":"Kwon","year":"2023","journal-title":"J Neurol"},{"key":"R14-20251230","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fneur.2020.00660","article-title":"MuSK-associated myasthenia gravis: Clinical features and management","volume":"11","author":"Rodolico","year":"2020","journal-title":"Front Neurol"},{"key":"R15-20251230","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/mus.27233","article-title":"Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody","volume":"63","author":"Zhou","year":"2021","journal-title":"Muscle Nerve"},{"key":"R16-20251230","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.0b013e3182407982","article-title":"Long-lasting treatment effect of rituximab in MuSK myasthenia","volume":"78","author":"D\u00edaz-Manera","year":"2012","journal-title":"Neurology"},{"key":"R17-20251230","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1136\/jnnp-2012-303664","article-title":"Long-term benefit of rituximab in MuSK autoantibody myasthenia gravis patients","volume":"84","author":"Keung","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R18-20251230","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1212\/WNL.0000000000004341","article-title":"Rituximab as treatment for anti-MuSK myasthenia gravis: Multicenter blinded prospective review","volume":"89","author":"Hehir","year":"2017","journal-title":"Neurology"},{"key":"R19-20251230","doi-asserted-by":"crossref","first-page":"736190","DOI":"10.3389\/fneur.2021.736190","article-title":"Effectiveness and safety of rituximab for refractory myasthenia gravis: A systematic review and single-arm meta-analysis","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Neurol"}],"container-title":["Acta Neurologica Taiwanica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ANT.ANT_113_0051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:54:42Z","timestamp":1786647282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ANT.ANT_113_0051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ant.ant_113_0051","relation":{},"ISSN":["1028-768X","3050-9173"],"issn-type":[{"value":"1028-768X","type":"print"},{"value":"3050-9173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2024-06-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}